SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001072613-19-000103
Filing Date
2019-02-14
Accepted
2019-02-14 15:08:32
Documents
1
Group Members
ARCH VENTURE FUND VIII OVERAGE, L.P.ARCH VENTURE PARTNERS VII, L.P.ARCH VENTURE PARTNERS VII, LLCARCH VENTURE PARTNERS VIII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 ARCH VENTURE FUND VII, L.P. - TWIST BIOSCIENCE CORPORATION -- SCHEDULE 13G archvii-twist_13g18289.htm SC 13G 285856
  Complete submission text file 0001072613-19-000103.txt   287747
Mailing Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631
Business Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631 773-380-6600
ARCH Venture Fund VII, L.P. (Filed by) CIK: 0001402439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH, SUITE 5 SAN FRANCISCO CA 94158 800-719-0671
Twist Bioscience Corp (Subject) CIK: 0001581280 (see all company filings)

IRS No.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13G | Act: 34 | File No.: 005-90866 | Film No.: 19605131
SIC: 2836 Biological Products, (No Diagnostic Substances)